Embecta (EMBC) CEO Dev Kurdikar joins Oliver Renick to give an overview of the company and discuss its 2Q earnings. He also talks about the impact of GLP-1 drugs. He then goes over the diabetes treatment market, as well as other emerging markets. Tune in to find out more about the stock market today.
======== Schwab Network ========
Empowering every investor and trader, every market day.
Subscribe to the Market Minute newsletter - schwabnetwork.com/subscribe
Download the iOS app - apps.apple.com/us/app/schwab-...
Download the Amazon Fire Tv App - www.amazon.com/TD-Ameritrade-...
Watch on Sling - watch.sling.com/1/asset/19192...
Watch on Vizio - www.vizio.com/en/watchfreeplu...
Watch on DistroTV - www.distro.tv/live/schwab-net...
Follow us on X - / schwabnetwork
Follow us on Facebook - / schwabnetwork
Follow us on LinkedIn - / schwab-network
About Schwab Network - schwabnetwork.com/about
#investing #trading #finance #stocks #global #equities #markets #stockmarket #stockmarkettoday #embecta #healthcare
Негізгі бет Embecta (EMBC) CEO on Diabetes Treatment Market
Пікірлер